Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6122353 | Journal of Hospital Infection | 2013 | 8 Pages |
Abstract
The low rate of HA-MRSA in the UK increases the relative proportion due to CA-MRSA, for which conventional risk-factor-based screening strategies may be less effective. Cost-benefit analyses of universal MRSA admission screening will need to take account of this new epidemiology.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
J.A. Otter, M.T. Herdman, B. Williams, O. Tosas, J.D. Edgeworth, G.L. French,